US Broker Ratings

Kestra Medical Technologies (KMTS) Investor Outlook: Exploring a 29% Potential Upside in the Healthcare Sector

Kestra Medical Technologies, Ltd. (NASDAQ: KMTS) presents a compelling opportunity for investors with a keen interest in the healthcare sector, specifically within the niche of medical instruments and supplies. The..

GRAIL, Inc. (GRAL) Investor Outlook: Navigating the Potential in Multi-Cancer Early Detection

GRAIL, Inc. (GRAL), a pioneering force in the healthcare sector, specifically in diagnostics and research, is making waves with its innovative approach to multi-cancer early detection. With a market capitalization..

PACS Group, Inc. (PACS) Stock Analysis: Exploring a Healthcare Giant’s 17.74% Potential Upside

PACS Group, Inc. (NASDAQ: PACS), a heavyweight in the healthcare sector, particularly within the medical care facilities industry, presents an intriguing investment opportunity for those looking to capitalize on its..

Astrana Health Inc. (ASTH) Stock Analysis: A Promising Healthcare Contender with 10% Upside Potential

Astrana Health Inc. (ASTH), a dynamic player in the healthcare sector, has recently caught the eye of investors with its impressive growth trajectory and strong market presence. With a market..

Certara, Inc. (CERT) Stock Analysis: Navigating Growth Potential in Health Information Services with 8.50% Upside

Certara, Inc. (CERT), a key player in the healthcare sector, offers a unique proposition for investors seeking exposure to the health information services industry. With a market capitalization of $1.08..

MannKind Corporation (MNKD) Stock Analysis: Exploring a 90.80% Potential Upside in Biotech Innovation

MannKind Corporation (NASDAQ: MNKD), a prominent player in the biotechnology industry, stands out with a compelling growth narrative that has caught the attention of investors. With a market capitalization of..

UFP Technologies, Inc. (UFPT) Stock Analysis: Exploring a 32% Potential Upside in the Medical Devices Sector

UFP Technologies, Inc. (NASDAQ: UFPT) is drawing considerable attention from investors, given its strategic positioning within the healthcare sector, specifically in medical devices. With a market capitalization of $1.9 billion,..

Viking Therapeutics (VKTX) Stock Analysis: Biotechnology’s Hidden Gem with a 154% Potential Upside

Viking Therapeutics, Inc. (NASDAQ: VKTX), a clinical-stage biopharmaceutical frontrunner, is attracting significant investor interest within the biotechnology sector. With a market capitalization of $4.22 billion, this San Diego-based company is..

Select Medical Holdings Corp (SEM) Stock Report: Navigating Stability in Healthcare with a 1.51% Dividend Yield

Select Medical Holdings Corporation (SEM), a key player in the healthcare sector, has carved a niche for itself within the medical care facilities industry. With a market capitalization of $2.05..

Kymera Therapeutics, Inc. (KYMR) Stock Analysis: A Promising Biotech with a 12.68% Upside

Kymera Therapeutics, Inc. (NASDAQ: KYMR) is carving out a niche in the biotechnology sector with its innovative approach to protein degradation. With a market capitalization of $9.14 billion, this clinical-stage..

Ascentage Pharma Group Internat (AAPG) Stock Analysis: Uncovering a Potential 158% Upside

Ascentage Pharma Group International (AAPG), a clinical-stage biotechnology company headquartered in Suzhou, China, is capturing investor attention with its ambitious pipeline and substantial market potential. Focused on developing innovative therapies..

Recursion Pharmaceuticals, Inc. (RXRX) Stock Analysis: Exploring a 150% Upside Potential in Biotechnology

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) presents a compelling case for investors in the healthcare sector, particularly those with an interest in biotechnology. With a market capitalization of $1.53 billion, Recursion..

IDEAYA Biosciences (IDYA) Stock Analysis: Exploring a 47.49% Upside Potential

IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a trailblazer in precision medicine oncology, is capturing the attention of investors with its promising pipeline and strategic collaborations. With a market capitalization of $3.41..

Kiniksa Pharmaceuticals (KNSA) Stock Analysis: Exploring a Compelling 8.86% Upside Potential

Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA) is drawing significant attention from investors within the healthcare sector. With a prominent focus on developing therapies for complex autoinflammatory diseases, Kiniksa stands out..

Schrodinger, Inc. (SDGR) Investor Outlook: Evaluating a 37% Potential Upside Amidst Unconventional Valuation Metrics

Investors with a keen eye on the healthcare sector may want to take a closer look at Schrödinger, Inc. (NASDAQ: SDGR), a company that stands at the intersection of technology..

Acadia Healthcare Company, Inc. (ACHC) Stock Analysis: Navigating Potential Amidst Revenue Growth and Analyst Consensus

Acadia Healthcare Company, Inc. (NASDAQ: ACHC), a key player in the U.S. behavioral healthcare sector, provides a comprehensive array of services aimed at addressing the mental health needs of communities..

Beam Therapeutics Inc. (BEAM) Stock Analysis: 98.66% Potential Upside Captivates Investors

Beam Therapeutics Inc. (NASDAQ: BEAM) stands at the forefront of innovation in the biotechnology sector, offering investors a unique opportunity with a potential upside of nearly 98.66% based on current..

Denali Therapeutics Inc. (DNLI): Analyst Consensus and Growth Potential Highlight a 49.56% Upside

Denali Therapeutics Inc. (NASDAQ: DNLI) stands at the forefront of the biotechnology sector, with a focus on developing innovative treatments for complex neurodegenerative and lysosomal storage diseases. Despite a challenging..

QuidelOrtho Corporation (QDEL) Stock Analysis: Exploring a 23.64% Potential Upside in the Healthcare Sector

QuidelOrtho Corporation (NASDAQ: QDEL), a notable player in the healthcare sector specializing in medical devices, presents a compelling opportunity for investors. Despite facing challenges reflected in its recent financial performance,..

LifeStance Health Group, Inc. (LFST) Stock Analysis: Stability in Healthcare with a 21.2% Revenue Growth

LifeStance Health Group, Inc. (NASDAQ: LFST) has emerged as a notable player in the healthcare sector, specifically within the medical care facilities industry. Headquartered in Scottsdale, Arizona, LifeStance Health Group..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds